Dr Naresh Konduru
Chief Research Scientist
Telangana
Expertise:
Analytical Chemistry
27
Publications
0
Projects
400
Scopus Citations
380
CrossRef
9 Years 11 Months Total Experience
Scopus
400
Citations
12
h-index
CrossRef
380
Citations
12
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Certificated Peer - Reviewer
2022
American Chemical Society
Certificated Peer - Reviewer
2024
Elsevier Research Academy
Community & Membership
No Data Found
There is currently nothing to display here.
Open Medicinal Chemistry Journal
Editorial Board MemberPersonal Details
Doctor of Philosophy
2019
N/A
Chief Research Scientist
Mar 2022 – Mar 2025
Unknown Organization
Chief Research Scientist
Apr 2021 – Mar 2022
Unknown Organization
Group Leader
Nov 2018 – Apr 2021
Unknown Organization
Assistant Manager
Mar 2015 – Aug 2018
Unknown Organization
Chemical Sciences
Scholarly Work
No Data Found
There is currently nothing to display here.
Development and Validation of Novel Stability-Indicating Methods for Selected Drugs of Cancer and Parkinson’s Diseases Using RP-HPLC and UPLC Techniques
Design, Synthesis and Biological Evaluation of Novel Chromones Having 3,4-Dihydropyrimidin-2(1H)-One Core at C-8 In Combination with Triazoles: New A-Glucosidase Inhibitors and Anti-Bacterial Agents
GITAM Deemed to be University
-
Application No. :
202541023785 A
Filed :
17-03-2025
Published :
21-03-2025
Published
Novel Chromone-Triazole Hybrids as Potential Anti-Diabetic Agents: Synthesis, A-Glucosidase Inhibition
GITAM Deemed to be University
-
Application No. :
202541023786 A
Filed :
17-03-2025
Published :
28-03-2025
Published
Design, Synthesis, and Biological Evaluation of Novel Chromone-Based Triazole Derivatives as Potent A-Glucosidase Inhibitors
GITAM Deemed to be University
-
Application No. :
202541023787 A
Filed :
17-03-2025
Published :
28-03-2025
Published
6.Estimating Butylated Hydroxytoluene in the presence of polymers such as Polyethylene Glycol and Polyethylene Oxide in Mirabegron Extended-Release Tablets
GITAM Deemed to be University
-
Application No. :
202541014055 A
Filed :
18-02-2025
Published :
28-02-2025
Published
Method for Analyzing Budesonide and Formoterol Fumarate Dihydrate in Dry Powder Inhalers using full factorial design
GITAM Deemed to be University
-
Application No. :
202541014056 A
Filed :
18-02-2025
Published :
28-02-2025
Published
4.Design and synthesis of alpha glycosidase inhibitors for 1-Benzyl-4-oxa-1,9-diazaspiro [5.5] undecane-2-one as an antidiabetic agent
GITAM Deemed to be University
-
Application No. :
202541000861 A
Filed :
03-01-2025
Published :
10-01-2025
Published
8-(Piperazin-1-YL)-3-(Pyridin-3-YL) Imidazo [1,5-A] Pyrazine and Amide Derivatives, Alpha Glucosidase Inhibitors
GITAM Deemed to be University
-
Application No. :
202541000862 A
Filed :
03-01-2025
Published :
10-01-2025
Published
A NOVEL CARBOCYCLIC NUCLEOSIDE ANALOG AND THE PROCESS FOR PREPARATION OF THE SAME
GITAM Deemed to be University
-
Application No. :
202441060702 A
Filed :
09-08-2024
Published :
06-09-2024
Published
AZASPIROOXINDOLINONE DERIVATIVES AND THE USE OF SAME IN CANCER THERAPY.
GITAM Deemed to be University
-
Application No. :
202441059533 A
Filed :
07-08-2024
Published :
06-09-2024
Published
AZASPIROOXINDOLINONE BASED PROTACS COMPOUNDS TOTARGET ITK AND BTK KINASES
GITAM Deemed to be University
-
Application No. :
202441059537
Filed :
07-08-2024
Published :
06-09-2024
Published
Scholarly Publications
Development and validation of apalutamide‐related substances method in solid dosage forms using HPLC
STABILITY INDICATING METHOD OF CARBIDOPA AND LEVODOPA ASSAY IN CARBIDOPA, LEVODOPA AND ENTACAPONE FILM COATED TABLETS BY RP- HPLC
10.13040/ijpsr.0975-8232.5(12).5530-38
Crossref: 2
Stability-Indicating Method of Entacapone-Related Substances Using UPLC in Finished Dosage Form
Open AccessDevelopment and Validation of a Stability-indicating Method for Ibrutinib: Identification and Separation of Degradation Products, Known and Genotoxic Impurities Using RP-HPLC/PDA and QDa Mass Detectors
A simple high‐performance liquid chromatography method development for Carbidopa and Levodopa impurities: Evaluation of risk assessment before method validation by Quality by Design approach
Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis C
Open AccessStability‐indicating reversed‐phase‐HPLC method development and validation for sacubitril/valsartan complex in the presence of impurities and degradation products: Robustness by quality‐by‐design approach
Determination of progesterone (steroid drug) in the semi‐solid dosage form (vaginal gel) using a stability‐indicating method by RP‐HPLC/PDA detector
Showing 1 to 8 of 27 publications